Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System

  • Georgina L. HoldEmail author
  • Richard Hansen
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 421)


Microbes within the gastrointestinal tract communicate with each other and with the host, which has profound effects on health and disease development. Only now, it is becoming apparent that how and when we acquire our own unique collection of “gut microbes” and also how we choose to maintain them is fundamental to our health. Helicobacter pylori is the most common bacterial infection worldwide, colonizing around half of the world’s population, and is the major risk factor for gastric adenocarcinoma. More recently, it has also been shown to have some beneficial effects in terms of protecting against the development of other diseases. Here, we review the current knowledge on how H. pylori has shaped gastrointestinal microbiota colonization and the host immune system with specific focus on the impact of H. pylori on the various microbiome niches of the gastrointestinal tract. We discuss how the presence of H. pylori influences the physiology of three major regions within the gastrointestinal tract—specifically the oesophagus, stomach and colon. We pay particular attention to the role of H. pylori under chronic inflammatory conditions including the development of cancer. With increased incidence of diseases such as eosinophilic oesophagitis, oesophageal adenocarcinoma and squamous cell carcinoma being attributed to the decline in H. pylori, their disease pathogenesis in light of changing H. pylori colonization is also discussed.


Helicobacter pylori Gastrointestinal microbiota Oesophageal microbiome Gastric microbiome Colonic microbiome 


  1. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L (2008) Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 3:e2836CrossRefGoogle Scholar
  2. Arnold IC et al (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory t cells. J Clin Invest 121:3088–3093CrossRefGoogle Scholar
  3. Arrieta MC et al (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7:307ra152Google Scholar
  4. Atherton JC, Blaser MJ (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475–2487CrossRefGoogle Scholar
  5. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 4:4202CrossRefGoogle Scholar
  6. Backhed F et al (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690–703CrossRefGoogle Scholar
  7. Benitez AJ et al (2015) Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 3:23CrossRefGoogle Scholar
  8. Bhat S et al (2011) Risk of malignant progression in barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057CrossRefGoogle Scholar
  9. Bik EM et al (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737CrossRefGoogle Scholar
  10. Blackett KL et al (2013) Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, barrett’s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 37:1084–1092CrossRefGoogle Scholar
  11. Brawner KM et al (2017) Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol 10:1169–1177CrossRefGoogle Scholar
  12. Castaño-Rodríguez N, Goh KL, Fock KM, Mitchell HM, Kaakoush NO (2017a) Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep 7:15957CrossRefGoogle Scholar
  13. Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM (2017b) Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 66:235–249CrossRefGoogle Scholar
  14. Chen Y, Blaser MJ (2008) Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 198:553–560CrossRefGoogle Scholar
  15. Chernikova DA et al (2018) The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birth. Pediatr Res.
  16. Coker OO et al (2018) Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67:1024–1032CrossRefGoogle Scholar
  17. Cook MB, Chow WH, Devesa SS (2009) Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br J Cancer 101:855–859CrossRefGoogle Scholar
  18. Corley DA et al (2008) Helicobacter pylori infection and the risk of barrett’s oesophagus: a community-based study. Gut 57:727–733CrossRefGoogle Scholar
  19. De Filippo C et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696CrossRefGoogle Scholar
  20. Dellon ES, Hirano (2018) Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 154:319–332CrossRefGoogle Scholar
  21. Den Hollander WJ et al (2015) Intergenerational reduction in Helicobacter pylori prevalence is similar between different ethnic groups living in a western city. Gut 64:1200–1208CrossRefGoogle Scholar
  22. Dicksved J, LindberG M, Rosenquist M, Enroth H, Jansson JK, Engstrand L (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58:509–516CrossRefGoogle Scholar
  23. Dominguez-Bello MG et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107:11971–11975CrossRefGoogle Scholar
  24. Eckburg PB et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638CrossRefGoogle Scholar
  25. Elliott DE, Urban JJ, Argo CK, Weinstock JV (2000) Does the failure to acquire helminthic parasites predispose to Crohn’s disease? Faseb J 14:1848–1855CrossRefGoogle Scholar
  26. Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC (2017) A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol Hepatol 2:32–42CrossRefGoogle Scholar
  27. El-omar E et al (1994) Low prevalence of helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 35:1385–1388CrossRefGoogle Scholar
  28. Ferreira RM et al (2018) Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67:226–236CrossRefGoogle Scholar
  29. Gao JJ et al (2018) Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer. Front Cell Infect Microbiol 8:202CrossRefGoogle Scholar
  30. Ge Z et al (2018) Helicobacter pylori-infected C57BL/6 mice with different gastrointestinal microbiota have contrasting gastric pathology, microbial and host immune responses. Sci Rep. 8(1):8014CrossRefGoogle Scholar
  31. Graham DY (1997) The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 350:70–71CrossRefGoogle Scholar
  32. Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol 61:1–14CrossRefGoogle Scholar
  33. Hansen R et al (2015) First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS ONE 10:e0133320CrossRefGoogle Scholar
  34. Harris JK et al (2015) Esophageal microbiome in eosinophilic esophagitis. PLoS ONE 10:e0128346CrossRefGoogle Scholar
  35. Higgins PD et al (2011) Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis 17:1398–1408CrossRefGoogle Scholar
  36. HomaN M, Orel R (2015) Are probiotics useful in Helicobacter pylori eradication? World J Gastroenterol 21:10644–10653CrossRefGoogle Scholar
  37. Hsieh YY et al (2018) Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep 8:158CrossRefGoogle Scholar
  38. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with barrett’s esophagus. N Engl J Med 365:1375–1383CrossRefGoogle Scholar
  39. Islami F, Kamangar F (2008) Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 1:329–338CrossRefGoogle Scholar
  40. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5:e9836CrossRefGoogle Scholar
  41. Kienesberger S et al (2018) Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep 14(6):1395–1407CrossRefGoogle Scholar
  42. Koenig JE et al (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108(suppl 1):4578–4585CrossRefGoogle Scholar
  43. Lee JY et al (2016) Helicobacter pylori infection with atrophic gastritis is an independent risk factor for advanced colonic neoplasm. Gut Liver 10:902–909CrossRefGoogle Scholar
  44. Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661–672CrossRefGoogle Scholar
  45. Luther J, Dave M, Higgins PD, Kao JY (2010) Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 16:1077–1084CrossRefGoogle Scholar
  46. Madan JC et al (2016) Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants. Jama Pediatr 170:212–219CrossRefGoogle Scholar
  47. Malaty HM et al (2002) Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359:931–935CrossRefGoogle Scholar
  48. Maldonado-contreras A et al (2011) Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 5:574–579CrossRefGoogle Scholar
  49. Marchesi JR et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65:330–339CrossRefGoogle Scholar
  50. May M, Abrams JA (2018) Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol 16:72–85CrossRefGoogle Scholar
  51. Mcilroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL (2018) Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management. Aliment Pharmacol Ther 47:26–42CrossRefGoogle Scholar
  52. Mendall MA et al (1992) Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 339:896–897CrossRefGoogle Scholar
  53. Moles L et al (2017) Bacterial diversity of the gastric content of preterm infants during their first month of life at the hospital. Frontiers in Nutrition 4:12CrossRefGoogle Scholar
  54. Nam JH et al (2017) Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms. Cancer Causes Control 28:107–115CrossRefGoogle Scholar
  55. Noto JM, Peek RM (2017) The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog 13:e1006573CrossRefGoogle Scholar
  56. Nowroozilarki N, Jamshidi S, Zahraei Salehi T, Kolahian S (2017) Identification of Helicobacter and Wolinella spp. In oral cavity of toy breed dogs with periodontal disease. Topics in Companion Animal Medicine 32:96–99CrossRefGoogle Scholar
  57. Oh B et al (2016) The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter 21:165–174CrossRefGoogle Scholar
  58. O’Keeffe J, Moran AP (2008) Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 13:1–19CrossRefGoogle Scholar
  59. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5:e177CrossRefGoogle Scholar
  60. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A 101:4250–4255CrossRefGoogle Scholar
  61. Pei Z, Yang L, Peek RM, Levine SM, Pride DT, Blaser MJ (2005) Bacterial biota in reflux esophagitis and barrett’s esophagus. World J Gastroenterol 11:7277–7283CrossRefGoogle Scholar
  62. Posselt G, Backert S, Wessler S (2013) The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal 11:77. Scholar
  63. Rad R et al (2006) CD25 +/FoxP3 + T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131:525–537CrossRefGoogle Scholar
  64. Rautava S, Luoto R, Salminen S, Isolauri E (2012) Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 9:565–576CrossRefGoogle Scholar
  65. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW (2001) Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 15:379–388CrossRefGoogle Scholar
  66. Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979–2990CrossRefGoogle Scholar
  67. Smolka AJ, Backert S (2012) How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol 47(6):609–618CrossRefGoogle Scholar
  68. Smolka AJ, Schubert ML (2017) Helicobacter pylori-induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol 400:227–252PubMedGoogle Scholar
  69. Snider EJ, Freedberg DE, Abrams JA (2016) Potential role of the microbiome in barrett’s esophagus and esophageal adenocarcinoma. Dig Dis Sci 61:2217–2225CrossRefGoogle Scholar
  70. Sohn SH et al (2017) Analysis of gastric body microbiota by pyrosequencing: possible role of bacteria other than Helicobacter pylori in the gastric carcinogenesis. J Cancer Prev 22:115–125CrossRefGoogle Scholar
  71. Sonnenberg A, Lash RH, Genta RM (2010) A national study of Helicobacter pylori infection in gastric biopsy specimens. Gastroenterology 139:1894–1901CrossRefGoogle Scholar
  72. Sonnenberg A, Turner KO, Spechler SJ, Genta RM (2017) The influence of Helicobacter pylori on the ethnic distribution of barrett’s metaplasia. Aliment Pharmacol Ther 45:283–290CrossRefGoogle Scholar
  73. Thorell K et al (2017) In vivo analysis of the viable microbiota and Helicobacter pylori transcriptome in gastric infection and early stages of carcinogenesis. Infect Immun 85:e00031–17CrossRefGoogle Scholar
  74. Yamamura K et al (2016) Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res 22:5574–5581CrossRefGoogle Scholar
  75. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z (2009) Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137:588–597CrossRefGoogle Scholar
  76. Yassour M et al (2016) Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8:343ra81Google Scholar
  77. Yatsunenko T et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227CrossRefGoogle Scholar
  78. Yu G et al (2017a) Gastric microbiota features associated with cancer risk factors and clinical outcomes: a pilot study in gastric cardia cancer patients from Shanxi, China. Int J Cancer 141:45–51CrossRefGoogle Scholar
  79. Yu G et al (2017b) Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol 7:302CrossRefGoogle Scholar
  80. Zhang H et al (2018) Helicobacter pylori colonization protects against chronic experimental colitis by regulating Th17/Treg balance. Inflamm Bowel Dis 24:1481–1492CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Microbiome Research Centre, St. George and Sutherland Clinical SchoolUniversity of New South WalesSydneyAustralia
  2. 2.Department of Paediatric GastroenterologyGlasgow Children’s HospitalGlasgowScotland, UK

Personalised recommendations